Skip to main content
Fig. 2 | BMC Health Services Research

Fig. 2

From: Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies

Fig. 2

EVIDEM alignment score by HTAb. HTAb: Health Technology Assessment body. SESCS: Servicio de Evaluación del Servicio Canario de Salud; SBU: Swedish Agency for Health Technology Assessment and Assessment of Social Services; HVB: Hauptverband der Österreichischen Sozialversicherungsträger; KCE: Belgian Health Care Knowledge Centre; INAMI-RIZIV: National Institute for Health and Disability Insurance; NCPHA: National Center of Public Health and Analyses; SUKL: State Institute for Drug Control; FIMEA: Finnish Medicines Agency; HAS: Haute Autorité de Santé; IQWiG: Institute for Quality and Efficiency in Health Care; OGYÉI: National Institute of Pharmacy and Nutrition; HIQA: Health Information and Quality Authority; NCPE: National Centre for Pharmacoeconomics; AIFA: Italian Medicines Agency; UCSC: Università Cattolica del Sacro Cuore; ZIN: Zorginstituut Nederland; AOTMiT: Agencja Oceny Technologii Medycznych i Taryfikacji; INFARMED: National Authority of Medicines and Health Products; UHIF: Union Health Insurance Fund; AEMPS: Agencia Española de Medicamentos y Productos Sanitarios; AETSA: Agencia de Evaluación de Tecnologías Sanitarias de Andalucía; AQUAS: Agència de Qualitat i Avaluació Sanitàries de Catalunya; TLV: Dental and Pharmaceutical Benefits Agency; NICE: National Institute for Health and Care Excellence; SMC: Scottish Medicines Consortium; AWTTC: All Wales Therapeutics and Toxicology Centre; NIPH: Norwegian Institute of Public Health; NoMA: Norwegian Medicines Agency; LBI-HTA: Ludwig Boltzmann Institute of Health Technology Assessment; AAZ: Agency for Quality and Accreditation in Health Care and Social Welfare; UoT: University of Tartu; G-BA: Gemeinsamer Bundesausschuss; RER: Regione Emilia-Romagna; NVD: The National Health Service; MOH: Ministry of Health Malta; MOH: Ministry of Health Slovakia; JAZMP: Agency for Medicinal Products and Medical Devices

Back to article page